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This study was designed to investigate the interaction between C. parapsilosis and human epithelial cells using monolayer cultures
and an engineered human oral mucosa (EHOM). C. parapsilosis was able to adhere to gingival epithelial cells and to adopt
the hyphal form in the presence of serum. Interestingly, when cultured onto the engineered human oral mucosa (EHOM), C.
parapsilosisformedsmallbioﬁlmandinvadedtheconnectivetissue.FollowingcontactwithC.parapsilosis,normalhumangingival
epithelialcellsexpressedhighlevelsofToll-likereceptors(TLR)-2,-4,and-6,butnotTLR-9mRNA.TheupregulationofTLRswas
paralleledbyanincreaseofIL-1β,TNFα,andIFNγ mRNAexpression,suggestingtheinvolvementofthesecytokinesinthedefense
against infection with C. parapsilosis. The active role of epithelial cells in the innate immunity against C. parapsilosis infection was
enhanced by their capacity to express high levels of human beta-defensin-1, -2, and -3. The upregulation of proinﬂammatory
cytokines and antimicrobial peptide expression may explain the growth inhibition of C. parapsilosis by the gingival epithelial cells.
Overall results provide additional evidence of the involvement of epithelial cells in the innate immunity against C. parapsilosis
infections.
1.Introduction
Fungal infections caused by Candida species are increasing,
particularly in immunocompromized individuals [1]. C.
albicans is the most common opportunistic fungal pathogen
involved in health problems encountered in humans. How-
ever, infections by other Candida species are gaining ground
worldwide,particularlyinnosocomialsettings.Theseemerg-
ing candidiases involve various Candida species, including C.
tropicalis, C. krusei, C. glabrata,a n dC. parapsilosis [2].
In comparison to other Candida species, C. parapsilosis
is largely distributed in nature. Unlike C. albicans and C.
tropicalis, C. parapsilosis is not an obligate human pathogen,
having been isolated from nonhuman sources [3]s u c ha s
domestic animals, insects, soil, and marine environments
[4]. C. parapsilosis is also a normal human commensal,
and it is one of the fungi most frequently isolated from
the subungal space of human hands. C. parapsilosis is a
commensalofhumanskin,anditspathogenicityislimitedby
intact integument. C. parapsilosis is notorious for its capacity
to grow in total parenteral nutrition and to form bioﬁlms on
cathetersandotherimplanteddevices,fornosocomialspread
by hand carriage, and for persistence in clinical units [5].
C. parapsilosis is of special concern in critically ill neonates
leading to high morbidity and mortality [6]. Furthermore,
C. parapsilosis has been isolated from the oral cavity of
of HIV-infected [7] and diabetic individuals [8]. Although
these studies document C. parapsilosis pathogenicity, further
investigationsarewarrantedtodeterminehowhumantissues
can interact with, and prevent C. parapsilosis infection.2 Mediators of Inﬂammation
It is well known that the ﬁrst line of defense against
exogenous microorganism infections lies in the tissues, such
as the skin and the oral mucosa [9, 10]. Both of these tissues
are layered with an epithelial structure containing over
95% epithelial cells that not only have an active defensive
role as a mechanical barrier but are also key players in
antimicrobial innate immunity [7, 10]. The attachment of
microorganisms such as C. parapsilosis to host cells is the
initial stage of the infection process, enabling candida to
survive and eventually colonize the host tissue during the
development of candidiasis. Recognition of adherent C.
parapsilosis by epithelial cells may involve speciﬁc receptors,
including Toll-likereceptors(TLRs)whichplayanactiverole
by recognizing pathogens of considerable target speciﬁcity
[11]. This recognition leads to a series of signaling events
that result in the necessary acute host responses required to
killthepathogens[12].Recentstudieshavedemonstratedthe
involvement of TLRs in the recognition of fungal pathogens
such as C. albicans, although less is known regarding the
function of these receptors following Candida infection [13,
14]. The Candida-killing activity of keratinocytes involves
TLR-2 and TLR-4 through NF-κBa c t i v a t i o n[ 15]. The
host’s response to infection is most likely due to the
diﬀerent recognition/activation patterns of these receptors
and the release of several proinﬂammatory cytokines [16,
17].
In response to C. albicans infection, oral epithelial cells
were shown to produce signiﬁcant amounts of IL-6, IL-8,
and TNFα [18, 19], which suggests that cytokines have a
signiﬁcant role in controlling oral infections. Controlling
Candida pathogenesis also involves the defensin family
(human β-defensins, HBDs) of antimicrobial peptides that
display broad-spectrum antimicrobial activity against a
large array of pathogens, such as Candida species [20].
Expressed by diﬀerent cell types, including epithelial cells,
these peptides have been suggested as playing an active role
in the commensal-to-pathogenic microorganism activity in
epithelial cells [21]. While the antifungal activity of HBDs
has been characterized to some extent [22], their exact role
in the host’s defense mechanism against fungal infection
remains unclear. Recent studies showed that the salivary
levels of HBD-1 and -2 were lower in patients with oral
candidiasis than in healthy individuals [23], whereas HBD-2
peptide expression was greater in human oral epithelia with
candidiasis than in normal oral epithelia [24].
Given that C. parapsilosis c a nb ea c q u i r e df r o md i ﬀerent
sites including soil and marine environments, and that
C. parapsilosis is considered as an emerging pathogen in
humans, we proposed to study (1) the virulence of C.
parapsilosis (transition from blastospore to hyphal form)
when cultured under the appropriate conditions (neutral pH
in the presence or absence of serum), and its susceptibility
to an antifungal agent (amphotericin B), (2) the ability of C.
parapsilosis to attach to normal human epithelial cells in a
monolayer culture and to form bioﬁlm when used to infect
EHOM in vitro, and (3) epithelial cell defenses against C.
parapsilosis infection by investigating the gene activation of
TLRs, antimicrobial peptides (HBD-1, -2, -3, and -4), and
pro-inﬂammatory cytokines (IL-1β,T N F α,a n dI F N γ).
2.MaterialsandMethods
2.1. Candida Species. C. parapsilosis was isolated from water
and sediment samples taken from various sites in the
Mediterranean Sea near the city of Gabes, Tunisia (North
Africa). The collected samples were immediately stored on
ice and transported to the laboratory. To isolate and identify
C. parapsilosis, a suspension of 50g of sediment from each
sediment sample was prepared in 100mL of saline solution.
The water samples were used undiluted. Both the sediment
suspensions (1mL) and the water samples (1mL) were laid
over Sabouraud dextrose agar (Difco; Becton-Dickinson,
Sparks, MD) enriched with yeast extract and were incubated
at 30◦C[ 25]. Following microorganism growth, separate
colonies were resuspended and seeded on Sabouraud dex-
trose agar gel and incubated at 30◦C for 24 hours. To
obtain homogenous yeast suspensions, separate colonies
were used to inoculate diﬀerent tubes containing Sabouraud
dextrose broth (Difco; Becton-Dickinson) supplemented
with0.1%glucoseandantibiotics(streptomycin/penicillinat
20μg/mL) to inhibit potential bacterial growth. The yeasts
were grown to the stationary phase overnight at 30◦Ci n
a shaking water bath. Blastoconidia were then collected,
washed with PBS, and subjected to speciﬁc identiﬁcation.
C. parapsilosis was selected following a rapid identiﬁcation
method based on the colorimetric detection of carbon
assimilation (Api ID 32C, Biom´ erieux SA, Marcy l’´ Etoile,
France). This identiﬁcation step was performed three times
using Candida subculture from the same single colony used
for the initial identiﬁcation test. We were thus able to
conﬁrm that the Candida species involved was indeed C.
parapsilosis. In some tests, we used C. albicans (ATCC 10231)
as a reference species. Following cultures, C. parapsilosis and
C. albicans were collected, washed with phosphate-buﬀered
saline (PBS), counted using a hemocytometer [9], adjusted
to 107/mL, and set aside for testing.
2.2. C. parapsilosis Susceptibility to Amphotericin-B. C.
parapsilosis (104/well) was seeded in a round-bottom 96-
well plate with or without various concentrations of
amphotericin-B (1,000-0ng/mL). The Candida cells in the
presence or absence of varied concentrations of antifungal
agent were incubated at 37◦C for 24 hours. C. parapsilosis
susceptibility to amphotericin-B was compared to that of
C. albicans (ATCC-10231). Candida growth was assessed
using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
t e t r a z o l i u mb r o m i d e )a s s a y ,w h i c hm e a s u r e sc e l lg r o w t h
as a function of mitochondrial activity [18]. Standard
growth curves were used to determine the concentrations
of viable C. parapsilosis and C. albicans following treat-
ment with amphotericin-B and the minimum inhibitory
concentration (MIC), referring to the lowest concentration
of amphotericin-B leading to a total inhibition of Candida
growth.
2.3. C. parapsilosis Virulence through the Blastospore-Hyphal
Transition. The transition from blastospore to hyphal form
is considered to be a virulence factor that enables Candida
to deeply penetrate the tissue and infect the host. WeMediators of Inﬂammation 3
therefore investigated the capacity of isolated C. parapsilosis
to adopt the hyphal form under favorable conditions. It
has been shown that temperature, proteins, and neutral
pH promote Candida transition [26]. We therefore cultured
C. parapsilosis under three diﬀerent conditions to assess
the presence/absence of hyphae. C. albicans (ATCC 10231)
was used as a reference. The germ tube formation of both
Candida strains was examined in the presence of 10% FCS,
at neutral pH (6 and 7), and ﬁnally at 30◦Ca n d3 7 ◦C. To
do so, Candida (106 cells) was grown in 2mL of Sabouraud
dextrose broth under one of the above mentioned conditions
for 3 and 6 hours. At the end of each culture period,
the Candida cultures were observed microscopically, and
the germ tubes and total cells were counted and used to
determine the transition percentage [18].
2.4. C. parapsilosis Adherence and Growth following
Contact with Gingival Epithelial Cells
2.4.1. Isolation and Culture of Oral Mucosal Cells. Small
pieces of palatal mucosa were biopsied from gingival graft
patients following their informed consent and with the
approval of the Universit´ e Laval Ethical Committee. The
epithelium was separated from the lamina propria using
thermolysin treatment (500μg/mL), after which time the
epithelial cells were isolated with a 0.05% trypsin-0.01 EDTA
solution. We used 0.125U/mL of collagenase-P (Boehringer
Mannheim, Laval, Qu´ ebec, Canada) to extract ﬁbroblasts
from the lamina propria. Oral epithelial cells (9 × 103
cells/cm2)w e r ec u l t u r e dw i t h1 . 3× 104/cm2 irradiated
mouse 3T3 ﬁbroblasts in Dulbecco’s modiﬁed Eagle-Ham’s
F12 (3:1) (DMEM) supplemented medium [27]. Oral
ﬁbroblasts (1 × 104 cells/cm2)w e r eg r o w ni nD u l b e c c o ’ s
modiﬁed Eagle (DME) supplemented medium. When the
cultures reached 70%–80% conﬂuence for the epithelial cells
and 100% for the ﬁbroblasts, the cells were detached and
used for various tests.
2.4.2. Contact between Candida and Epithelial Cells. Cells
were seeded in six-well tissue culture plates and grown
at 37◦Ci na n8 %C O 2 atmosphere. At 80% conﬂuence,
epithelial cell monolayers were pulsed with C. parapsilosis
(105 cells/cm2) for 3, 6, 12, and 24 hours. At the end of
each contact period, the monolayers were used to assess C.
parapsilosis adhesion and growth. To assess C. parapsilosis
adhesion, monolayer cultures were washed six times with
PBS and ﬁxed with 40% methanol and 60% acetone for
10 minutes. The cells were washed twice with PBS and
stained with crystal violet. The stained monolayers were then
examined under an optical microscope and photographed.
To assess the growth of C. parapsilosis following contact
with the epithelial cells, culture medium was used to collect
nonadherent C. parapsilosis as well as those adhering to
the cells. This collection was performed by treating the
monolayer epithelial cells with 1% (v/v) Triton X-100 in PBS
to lyse the epithelial cells with no side eﬀect on the Candida.
A pellet of C. parapsilosis collected from the culture medium
was then mixed with those adhering to and entering the
epithelial cells. C. parapsilosis viability and numbers under
eachconditionweredeterminedbytrypanbluedyeexclusion
[9].
2.4.3. Eﬀect of C. parapsilosis on Epithelial Cell Viability.
Immediately after each contact period, cells were detached
from the culture ﬂasks using a 0.05% trypsin-0.01 M EDTA
solution for 20 minutes at 37◦C. The cells were washed twice
with DMEM-supplemented culture medium. The pellet was
resuspended in 500μLo fD M E Ma n d5 0μL of each epithelial
cell suspension were withdrawn to assess the percentage of
viable cells using the trypan blue exclusion technique [19].
2.5. Eﬀect of C. parapsilosis on Tissue Structure
2.5.1. Preparation of Engineered Human Oral Mucosa. Using
normal primary oral epithelial cells and oral ﬁbroblasts, we
produced engineered human oral mucosa (EHOM) [28].
Brieﬂy, oral ﬁbroblasts were mixed with bovine skin collagen
(BD Biosciences, Mississauga, ON, Canada) to produce
the lamina propria. Tissue was grown in Dulbecco-Vogt
modiﬁed Eagle’s medium supplemented with 5% fetal calf
serum for 4 days. The oral epithelial cells were then seeded
onto the lamina propria, and the tissue was grown in the
presence of 10% fetal calf serum. Once the epithelial cells
reached conﬂuence, the EHOM were raised to the air-liquid
interface for 5 days to enable the epithelium to stratify.
Following this air-liquid interface culture, the EHOM were
used to study the tissue interaction of C. parapsilosis.
2.5.2. Tissue Structure following C. parapsilosis Infection. To
testtheeﬀectofC.parapsilosisontissuestructure,theEHOM
tissue was infected with 1 × 106 cells/cm2 of C. parapsilosis.
Tissue untreated with Candida cells served as the control.
Following a 24-h infection period, the tissue was collected
and used for histological analyses. We collected multiple
biopsies from each infected EHOM and stained them with
hematoxylin and eosin. Each slide was assigned a number
and blindly analyzed for tissue structure and the presence of
C. parapsilosis at regular intervals using a calibrated image
analysis system [29].
2.6. Eﬀect of C. parapsilosis on the Expression of
TLRs, β-Defensins, and Pro-Inﬂammatory Cytokines by
Gingival Epithelial Cells
2.6.1. Stimulation of Epithelial Cells with C. parapsilosis.
Epithelial cells were detached from 75-cm2 culture ﬂasks
using trypsin, washed twice in culture medium, counted,
seeded into six-well tissue culture plates (Falcon, Becton
Dickinson, Lincoln Park, NJ) at 2.5 × 105 cells/well, and
ﬁnally incubated in an 8% CO2 atmosphere at 37◦C. After
5 days of culture, the epithelial cells reached approximately
80% conﬂuence. They were then stimulated or not with C.
parapsilosis (105/cm2) and were cultured again for 6 and 24
hours. Total RNA was extracted from the cells following each
culture period.4 Mediators of Inﬂammation
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Figure 1: Sensitivity of C. parapsilosis to amphotericin-B. The
yeast was cultured in the presence of various concentrations of
amphotericin-B for 24 hours and its growth was assessed by
MTT assay. Quantiﬁcation of live C. parapsilosis was obtained
using a standard live curve. The eﬀect of the antifungal agent on
C. parapsilosis was compared to that on C. albicans. Results are
presented as means ± SD of six diﬀerent experiments.
2.6.2.RNAExtractionandQuantiﬁcation. TotalcellularRNA
content was extracted using the Illustra RNAspin Mini
(GE Health Care UK Limited, Buckingham, UK), while
RNA concentration, purity, and quality were determined by
means of the Experion system and RNA StdSens analysis
kit according to instructions provided by the manufacturer
(Bio-Rad, Hercules, CA).
2.6.3. Quantitative Real-Time RT-PCR. RNA (1μgo fe a c h
sample) was reverse transcripted into cDNA using Mal-
oney murine leukemia virus (M-MLV) reverse transcriptase
(Invitrogen Life Technologies, Mississauga, ON, Canada)
and random hexamers (Amersham Pharmacia Biotech,
Inc., Baie d’Urf´ e, QC, Canada). RT conditions were 10
minutes at 65◦C, 1 hour at 37◦C, and 10 minutes at 65◦C.
Quantitative PCR was carried out as previously described
[18]. Amounts of mRNA transcripts were measured using
the Bio-Rad CFX96 real-time PCR detection system (Bio-
Rad, Mississauga, ON, Canada). Reactions were performed
using a PCR supermix from Bio-Rad (iQ SYBR Green
supermix). Primers (Table 1) were added to the reaction mix
at a ﬁnal concentration of 250nM. Five microliters of each
cDNA sample was added to a 20μL PCR mixture containing
12.5μL of iQ SYBR Green supermix (Bio-Rad) and 0.5μL
of speciﬁc primers (TLR-2, TLR-4, TLR-6, TLR-9, HBD-1,
HBD-2, HBD-3, HBD-4, GAPDH, IL-1β,T N F α,a n dI F N γ)
(Medicorp, Inc., Montr´ eal, QC, Canada) and 7μLo fR N a s e
and DNase free water (MP Biomedicals, Solon, OH). Each
reaction was performed in a Bio-Rad MyCycler Thermal
Cycler (Bio-Rad). For the qPCR, the CT was automatically
determined using the accompanying Bio-Rad CFX manager.
Thermocycling conditions for the TLRs were 5 minutes at
95◦C, followed by 45 cycles of 95◦C for 15 seconds, and
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Figure 2: Blastospore-to-hyphal transition of C. parapsilosis.
Following culture at diﬀerent temperatures and neutral pH with
or without proteins (serum), the percentage of C. parapsilosis germ
tubes was determined by dividing the number of hyphae over the
total number of cells (blastospore and hyphae) in each culture
condition. The mean relative values for six separate experiments are
shown. C. albicans w a su s e da sar e f e r e n c es t r a i nt oC. parapsilosis.
60◦C for 30 seconds and 72◦C for 30 seconds, with each
reaction done in triplicate. For the HBDs, the thermocycling
conditions were 95◦C for 3 minutes, followed by 45 cycles
of 95◦C for 10 seconds, 63◦C for 10 seconds, and 72◦C
for 30 seconds, with each reaction performed in triplicate.
For the cytokines, the conditions were 95◦Cf o r1 0m i n u t e s ,
followed by 40 cycles of 95◦C for 15 seconds, 60◦Cf o r6 0
seconds, and 72◦C for 30 seconds, with each reaction done inMediators of Inﬂammation 5
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Figure 3: C. parapsilosis adhesion to the gingival epithelial monolayer culture. Human gingival cells were grown up to 80% conﬂuence,
pulsed with C. parapsilosis or C. albicans, and incubated for 6 hours with or without serum. Following this culture period, the supernatant
containing nonattached Candida was discarded, and the cultures were washed and stained with Cristal violet. Representative photographs
are presented. Magniﬁcation: 250×.
e
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Figure 4: Eﬀect of C. parapsilosis on tissue structure and the formation of a bioﬁlm on the engineered human oral mucosa. Histological
features of EHOM following exposure to C. parapsilosis. EHOM tissue was infected with (a) no Candida cells (uninfected control) and (b,
c) C. parapsilosis strain. Note the formation of a bioﬁlm on the tissue (b) and the presence of C. parapsilosis in the connective tissue (c).
Representative photographs of four diﬀerent experiments are shown (two EHOMs per experiment). Magniﬁcation ×2 5 0f o rp a r t s( a )a n d
(b), and ×600 for part (c). e: epithelium.
triplicate. The speciﬁcity of each primer pair was veriﬁed by
the presence of a single melting temperature peak. GAPDH
produced uniform expression levels varying by less than
0.5CTs between sample conditions and was therefore used
as a reference gene for this study.
2.7.MeasurementofAntimicrobialPeptidesSecretionfollowing
Tissue Contact with C. parapsilosis. To quantify human β-
defensins hBD2 and hBD3, culture supernatants obtained
from duplicate or triplicate experiments were analyzed by
sandwich enzyme-linked immunosorbent assays (ELISA).
Once the collection of supernatants was cleared by centrifu-
gation, HBD2 and HBD3 were measured in triplicate using
an ELISA kit (Phoenix Pharmaceuticals Inc., Burlingame,
California, USA) according to the manufacturer’s instruc-
tions. To do so, 50μL volumes of undiluted supernatants
were used to perform the quantitative analyses. Following
incubation, the plates were read at 450nm and analyzed6 Mediators of Inﬂammation
Table 1: Primer sequences used for the q-RT-PCR.
Gene name Primers sequences Product size
(bp)
TLR-2 sense: 5 -GCCTCTCCAAGGAAGAATCC-3  144
antisense: 5 -TCCTGTTGTTGGACAGGTCA-3 
TLR-4 sense: 5 -AATCTAGAGCACTTGGACCTTTCC-3  116
antisense: 5 -GGGTTCAGGGACAGGTCTAAAGA-3 
TLR-6 sense: 5 -CATCCTATTGTGAGTTTCAGGCAT-3  121
antisense: 5 -GCTTCATAGCACTACATCCCAAG-3 
TLR-9 sense: 5 -GGACCTCTGGTACTGCTTCCA-3  151
antisense: 5 -AAGCTCGTTGTACACCCAGTCT-3 
β1-defensin sense: 5 -GCCTCTCCCCAGTTCCTGAA-3  82
antisense:
5 -GCAGAGAGTAAACAGCAGAAGGTA-3 
β2-defensin sense: 5 -TGTGGTCTCCCTGGAACAAAAT-3  105
antisense: 5 -GTCGCACGTCTCTGATGAGG-3 
β3-defensin sense: 5 -CTTCTGTTTGCTTTGCTCTTCCT-3  138
antisense: 5 -CTGTTCCTCCTTTGGAAGGCA-3 
β4-defensin sense: 5 -CACTCTACCAACACGCACCTAG-3  133
antisense: 5 -CGCAACTGGAACCACACACT-3 
IL-1β sense: 5 -CTGTCCTGCGTGTTGAAAGA-3  69
antisense: 5 -TTGGGTAATTTTTGGGATCTACA-3 
IFNγ sense: 5 -GGCATTTTGAAGAATTGGAAAG-3  111
antisense: 5 -TTTGGATGCTCTGGTCATCTT-3 
TNFα sense: 5 -CAGCCTCTTCTCCTTCCTGAT-3  122
antisense: 5 -GCCAGAGGGCTGATTAGAGA-3 
GAPDH sense: 5 -GGTATCGTCGAAGGACTCATGAC-3  180
antisense: 5 -ATGCCAGTGAGCTTCCCGTTCAGC-3 
Table 2: Growth of C. parapsilosis following contact with human
oral epithelial cells, and viability of epithelial cells after contact with
Candida.
Contact time (h)
Nb. of C.
parapsilosis &
(×105/cm2)
Viability of
epithelial cells
(%)
31 . 6 ± 0.7 97.3 ± 0.01
60 . 9 ± 0.03∗∗ 97.0 ± 0.02
12 0.1 ± 0.09∗∗ 96.5 ± 0.32
24 0.03 ± 0.01∗∗ 96.9 ± 0.37
&C. parapsilosis was seeded onto epithelial cell culture at 105 cells/cm2.
To assess the growth of Candida following contact with the epithelial cells,
nonadherent(inthesupernatant)andadherent(onthemonolayerepithelial
cell cultures) C. parapsilosis were collected and enumerated. To assess the
viability of epithelial cells, cultures were treated with trypsin and cells were
washed twice then viable epithelial cells were determined using trypan bleu
exclusion test.
∗∗P ≤ .01 is level of signiﬁcance for growth inhibition of C. parapsilosis in
infected oral epithelial cell cultures compared to initial seeding concentra-
tion of C. parapsilosis.
using a Microplate Reader Model 680 (Bio-Rad Laboratories
Ltd, Mississauga, ON). The experiments were repeated three
times and the means ± standard deviation (SD) were
presented.
2.8. Statistical Analyses. Experimental values are given as
means ± SD. The statistical signiﬁcance of diﬀerences
between the control values and the test values was deter-
mined using a one-way ANOVA. Posteriori comparisons
were done using Tukey’s method. Normality and variance
assumptions were veriﬁed using the Shapiro-Wilk test and
the Brown and Forsythe test, respectively. All of the assump-
tions were fulﬁlled. P-values were declared signiﬁcant at
0.05. Data were analyzed using the SAS version 8.2 statistical
package (SAS Institute, Inc., Cary, NC).
3. Results
3.1. Susceptibility of C. parapsilosis to Amphotericin-B. Can-
dida strains were isolated from Mediterranean Sea water
and sediment samples. Api ID 32C analysis revealed that
C. parapsilosis was the most isolated strain. Following the
extraction and identiﬁcation of C. parapsilosis,w ew e r e
concerned about its possible side eﬀects on humans; we
therefore tested its susceptibility to an antifungal agent.
Figure 1 shows that the growth rate of C. parapsilosis was
very slow compared to that of C. albicans (ATCC 10231).
In the presence of amphotericin B, the MIC was in the rage
of 60ng/mL for both C. albicans and C. parapsilosis,w h i c hMediators of Inﬂammation 7
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Figure5:QuantiﬁcationofmRNAexpressionlevelsofTLR-2,-4,-6,and-9bygingivalepithelialcellsfollowinginfectionwithC.parapsilosis.
Gingival epithelial cells were cultured with or without C. parapsilosis for 6 and 24 hours. Total RNA content was extracted from the cells
following each culture period and was used for quantitative RT-PCR of the TLR-2, -4, -6, and -9 genes, as described in Section 2. Results are
presented as a fold expression of the gene in the test sample compared to this gene expression in the control. Data are expressed as means ±
SD from triplicate assays of three diﬀerent experiments. (a) TLR-2 expression, (b) TLR-4 expression, (c) TLR-6 expression, and (d) TLR-9
expression. GEC: gingival epithelial cells.
suggests that C. parapsilosis was as sensitive to amphotericin
Ba sC. albicans.
3.2. Isolated C. parapsilosis Was Able to Adopt the Filamentous
Form. As the phenotype change (i.e., transition from yeast
to ﬁlamentous form) of Candida is one of the major
determinants of its virulence and is closely associated with
its ability to cause disease, we investigated C. parapsilosis
transition under various culture conditions. As shown in
Figure 2,b o t hC. albicans and C. parapsilosis were able to
adopt the ﬁlamentous form under any favorable conditions.
Indeed, at neutral pH with 10% serum, C. parapsilosis
displayed ﬁlamentous forms after 3 and 6 hours of culture.
The same observations were obtained at acidic pH in the
presence of serum.
3.3. C. parapsilosis Adhered to Gingival Epithelial Cells.
Adhesion of C. parapsilosis to epithelial cells was investigated
at 6 and 24 hours postinfection. As shown in Figure 3,
diﬀerent clamps of C. parapsilosis were present on the
epithelial cell monolayer 6 hours after infection and were
distributed throughout the culture. Of great interest was that
in the presence of serum, these clamps were bigger than
were those without serum. Also, with serum, morphological
changes (hyphae forms) were more visible as compared to
culture without serum. The same results were obtained at
24 hours postinfection (data not shown). C. parapsilosis thus
adhered to normal human gingival epithelial cells and adopt
ﬁlamentous phenotype, which may explain its pathogenic
capacity in humans.8 Mediators of Inﬂammation
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Figure 6: Quantiﬁcation of mRNA expression levels of HBD-1, -2, -3, and -4 by gingival epithelial cells following infection with C.
parapsilosis. Gingival epithelial cells were cultured with or without C. parapsilosis for 6 and 24 hours. Total RNA was extracted from the
cells following each culture period and was used for quantitative RT-PCR of the HBD-1, -2, -3, and -4 genes, as described in Section 2.
Results are presented as a fold expression of the gene in the test sample compared to this gene expression in the control. Data are expressed
as means ± SD from triplicate assays of three diﬀerent experiments. (a) HBD-1 expression, (b) HBD-2 expression, (c) HBD-3 expression,
and (d) HBD-4 expression. GEC: gingival epithelial cells.
3.4.EﬀectofHumanGingivalEpithelialCellsonC.parapsilosis
Growth. As epithelial cells downregulate C. albicans growth
[9], and because C. parapsilosis adheres to gingival epithelial
cells, we investigated the eﬀect of epithelial cells on the
growth of C. parapsilosis. Table 2 shows that following
contact with epithelial cells, all of the collected C. parapsilosis
were alive, yet their numbers were signiﬁcantly reduced,
varying from 1.5 × 105/cm2 after a 3-h contact to approx-
imately 3 × 103/cm2 after a 24-h contact. These results
suggest that gingival epithelial cells inhibited the growth
of C. parapsilosis. It is interesting to note that to some
extent, epithelial cells killed oﬀ C. parapsilosis because at
the longer contact period (24 hours), there were far less (3
× 103/cm2) C. parapsilosis present than what was initially
used (105/cm2) to infect the epithelial cell cultures. On the
other hand, epithelial cell viability following contact with
C. parapsilosis was investigated showing that (Table 2)n o
signiﬁcant diﬀerences were obtained between C. parapsilosis-
infected and uninfected cultures, either in terms of cell
viability or total numbers of viable cells.
3.5.C.parapsilosisFormedaBioﬁlmontheEngineeredHuman
Oral Mucosa Tissue Which May Have Contributed to Tissue
Disorganization. To direct our studies closer to the in vivo
setting, we examined the ability of C. parapsilosis to form
bioﬁlm on the in vivo-like EHOM model, which mimics
the physiologic conditions and complex structure of the oral
mucosaintermsofthree-dimensionalstructure,relationship
between the various cell types, and secretion of soluble
factors [28]. Our results reveal that C. parapsilosis adheredMediators of Inﬂammation 9
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Figure 7: Quantiﬁcation of HBD2 and HBD3 levels secreted by gingival epithelial cells following infection with C. parapsilosis. Gingival
epithelial cells were cultured with or without C. parapsilosis for 6 and 24 hours. Supernatants were collected and used to quantify HBD2 (a)
and HBD3 (b) using ELISA kits. Data are means ± SD of three separate experiments. The levels of signiﬁcance were obtained by comparing
the amount of AMP obtained with unstimulated samples to that obtained with samples stimulated C. parapsilosis.
to and formed bioﬁlms on the EHOM layers (Figure 4(b),
arrows). More importantly, C. parapsilosis did penetrate the
tissue to reach the lamina propria of the EHOM, there-
fore, showing an invasion of the tissue layers (Figure 4(c),
arrows). This invasion by C. parapsilosis may explain the
disorganization observed in the infected tissue (Figure 4(b))
compared to the noninfected tissue (Figure 4(a)). Indeed,
the tissue disorganization was characterized by diﬀerentiated
cells (large cells, faint nuclei, large cytoplasm) in the upper
layers of the epithelium, and the absence of layers including
the stratum corneum. These studies show that C. parapsilosis
was able to form a bioﬁlm on the tissue to deeply invade
the connective tissue, which contributed to damaging the
structure of the mucosal tissue.
3.6. C. parapsilosis Modulated TLR Expression by Normal
Human Gingival Epithelial Cells. Oral mucosa represents a
majorinteractionsitebetweenthehostandtheenvironment.
The host’s line of defense at this interface is therefore
critical to controlling infection. Epithelial cells are involved
in the control of C. albicans pathogenesis through diﬀerent
pathways, including speciﬁc receptors such as TLRs [11, 17].
As epithelial cells downregulate C. parapsilosis growth, we
sought to investigate the involvement of TLR expression
by epithelial cells in the recognition of C. parapsilosis.
Using quantitative RT-PCR, we showed (Figure 5(a)) that C.
parapsilosis signiﬁcantly increased TLR-2 mARN expression,
at 6 (P<. 05) and 24 hours (P<. 005) of contact. It
should be noted that the epithelial cells in contact with C.
parapsilosis expressed more TLR-2 mRNA at 24 hours than
at 6 hours (Figure 5(a)). Following TLR-2 activation, we
then examined TLR-4 expression by the gingival epithelial
cells. As demonstrated in Figure 5(b), the cells expressed
high levels of TLR-4 mRNA later (24 hours), in response to
C. parapsilosis. The TLR-6 mRNA expression (Figure 5(c))
showed that C. parapsilosis induced a signiﬁcant increase of
TLR-6 mRNA expression by epithelial cells at 6 hours of
culturebutnotat24hours.Finally,C.parapsilosismodulated
TLR-9 expression diﬀerently. As shown in Figure 5(d), C.
parapsilosis signiﬁcantly (P<. 05, P<. 001) reduced
TLR-9 gene expression. Overall results suggest that gingival
epithelial cells involve TLR-2, -4, and -6, but not TLR-9 in
the defense against C. parapsilosis infections.
3.7. Human Gingival Epithelial Cells Prevented C. parapsilosis
Infection through β-DefensinExpression(HBD-1,HBD-2,and
HBD-3). Antimicrobial peptides (AMP) are a component of
mammalian innate immunity and are expressed by various
celltypestopreventmicrobialinfection.Itiswellknownthat
epithelial cells involve defensins to control bacterial infection
through TLRs. As we revealed that TLR expression was
modulated by C. parapsilosis (Figure 5), we also examined
the expression of HBD-1, HBD-2, HBD-3, and HBD-4 in
response to stimulation with C. parapsilosis.A sr e p o r t e di n
Figure 6(a), C. parapsilosis signiﬁcantly (P<. 05) increased
HBD-1 mRNA expression by epithelial cells at 24 hours. We
also showed (Figure 6(b)) a signiﬁcant increase of HBD-2
at 6 hours (P<. 05) and 24 hours (P<. 03) following
cell contact with C. parapsilosis. Epithelial cells expressed
elevated HBD-3 mRNA levels at 6 but not at 24 hours
in response to C. parapsilosis stimulation (Figure 6(c)).
However, HBD-4 mRNA remained unchanged at the early10 Mediators of Inﬂammation
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Figure 8: Quantiﬁcation of mRNA expression levels of IL-1β,T N F α, and IFNγ by gingival epithelial cells following infection with C.
parapsilosis. Gingival epithelial cells were cultured with or without C. parapsilosis for 6 and 24 hours. Total RNA was extracted from the
cells following each culture period and was used for quantitative RT-PCR of the IL-1β,T N F α, and IFNγ genes, as described in Section 2.
Results are presented as a fold expression of the gene in the test sample compared to this gene expression in the control. Data are expressed
as means ± SD from triplicate assays of three diﬀerent experiments. (a) IL-1β expression, (b) TNFα expression, and (c) IFNγ expression.
GEC: gingival epithelial cells.
contact period but decreased at the longer contact period
(24 hours) (Figure 6(d)). These results suggest that gingival
epithelial cells control C. parapsilosis pathogenesis through
antimicrobial peptides, particularly HBD-1, HBD-2, and
HBD-3. To conﬁrm these results, we analysed the secretion
of HBD2 and HBD3 following C. parapsilosis infection. As
showed in Figure 7, the basal level of HBD2 and HBD3
increased following tissue infection with C. parapsilosis. This
supports the increased mRNA gene expression of AMP by
epithelial cells in response to C. parapsilosis.
3.8. Gingival Epithelial Cells Expressed High Levels of Proin-
ﬂammatory Cytokines against C. parapsilosis. Cytokine pro-
teins IL-1β,T N F α,a n dI F N γ are active in controlling
oral infections and maintaining the symbiotic relationship
between the oral microbial community and the host. We
therefore examined the gene expression of these interleukins
by gingival epithelial cells following contact with C. para-
psilosis. As shown in Figure 8(a), epithelial cells expressed
ah i g hl e v e lo fI L - 1 β mRNA in response to C. parapsilosis.
This elevated expression was present at 6 and 24 hoursMediators of Inﬂammation 11
postinfection but was not time-dependent. C. parapsilosis
also stimulated the epithelial cells to express a high level
of TNFα mRNA basically after 24 hours of stimulation
(Figure 8(b)). On the other hand, C. parapsilosis signiﬁcantly
(P<. 001) increased the IFNγ mARN expression by the
gingival epithelial cells at early (6 hours) contact period, but
decreased IFNγ mRNA expression at 24 hours postinfection.
Overall results suggest that gingival oral epithelial cells pre-
vented C. parapsilosis’s side eﬀect through pro-inﬂammatory
cytokines including IL-1β,I F N γ,a n dT N F α.
4. Discussion
It is well documented that nonalbicans Candida (NAC)
species cause high levels of human candidiasis [2]w h i c hi s
more prevalent in immunocompromized patients. The most
involved NAC species in human disease are C. tropicalis, C.
krusei,a n dC. glabrata [30, 31]. To these we add another
emerging species, C. parapsilosis, responsible for multiple
human candidiasis cases [32]. In comparison to other
Candida species, C. parapsilosis has an extensive distribution
in nature. Unlike C. albicans and C. tropicalis, C. parapsilosis
is not an obligate human pathogen, having been isolated
from nonhuman sources [3] such as domestic animals,
insects, soil, and marine environments [4]. This raises
the question as to whether humans may be contaminated
by C. parapsilosis. Based on available data, the answer to
this question may reside in the interaction of humans
with various environmental sites such as rivers, recreational
locations (beaches), or through marine products. Indeed,
this study showed the presence of C. parapsilosis in sea
water and sediments. It also conﬁrms previously reported
data [33] showing the presence of diﬀerent Candida species
(including C. parapsilosis) in marine sites. As C. parapsilosis
may reach humans via various exposures, we investigated the
susceptibility of the yeast to antifungal agent amphotericin-
B. Interestingly, we found that C. parapsilosis isolated from
sea water and sediment was sensitive to this antifungal
agent, thus conﬁrming previous data [32]. Although isolated
C. parapsilosis was sensitive to the antifungal agents, we
pursued further to investigate its interaction with host cells
such as normal human gingival epithelial cells. Our results
indicate that isolated C. parapsilosis adhered to gingival
epithelial cells, and adapted ﬁlamentous form. However, the
hyphae from was not well expressed as the one observed
with C. albicans, which is in accordance with previously
reported data [33, 34]. However, even if it did not translate
from blastospore to clear hyphal form, C. parapsilosis was
able to reach the connective tissue of the infected EHOM.
This invasion may be due to (1) the capacity of some
C. parapsilosis cells to overcome the epithelial cells’ innate
defenses or (2) the large number of C. parapsilosis cells
(106/cm2 of tissue) used in our experiments. This large
number may have overwhelmed the capacity of the epithelial
structure to prevent C. parapsilosis invasion. Thus, further
studiesarerequiredtoshedlightonthepossiblemechanisms
used by C. parapsilosis to invade gingival tissue.
The adhesion and interaction mechanisms between C.
parapsilosis and epithelial cells are not well known, and
most of the available data corresponds to studies performed
speciﬁcally with C. albicans [9, 10]. According to these
studies, C. parapsilosis sensing by human epithelial cells
may be through speciﬁc receptors such as TLRs. In light
of this, our study conﬁrms an increase of TLR-2, TLR-
4, and TLR-6, but not TLR-9 mARN expression following
interaction between C. parapsilosis and human epithelial
cells. Although ours is the ﬁrst study with C. parapsilosis,
it conﬁrms the involvement of the TLR (-2, -4, and -6)
pathway in the interaction between host and other Candida
species including C. albicans [10, 17, 35]. The nonactivation
of TLR-9 mRNA expression by C. parapsilosis is surprising,
as TLR-9 reportedly plays an active role in the recognition
of C. albicans [36]. The recognition of C. albicans and C.
parapsilosis by epithelial cells appears to involve TLR-9 in
ad i ﬀerent manner. This may constitute an experimental
clinical marker to discriminate between C. albicans and C.
parapsilosis infections. Further studies will provide insight
on this possible pathway. Additional research is also required
to shed light on the role of each of the TLR2, 4, 6, and
9 in controlling C. parapsilosis infection, and how the pro-
inﬂammatory response is triggered and by which part of C.
parapsilosis.
It is well known that TLRs play a critical role as they
recognize pathogens and activate the adaptive immune
response [35]. In this study, epithelial cells, another key
member of the innate immunity network, expressed var-
ious inﬂammatory mediators (IL-1β,T N F α,a n dI F N γ)
following contact with C. parapsilosis. These ﬁndings suggest
that epithelial cells support the host’s defenses against C.
parapsilosis through proinﬂammatory cytokines, which is
in agreement with previously reported data involving C.
albicans [19, 37, 38]. Proinﬂammatory cytokines IL-1β and
TNFα were augmented by the C. parapsilosis-infected oral
epithelial cells at early and late infection periods, while
IFNγ was involved only at early defense phase, as previously
reported with C. albicans [9]. This study therefore conﬁrms
the capacity of oral epithelial cells, through the expression of
IL-β,T N F α,a n dI F N γ,t oc o n t r o lC. parapsilosis infection.
In vitro studies have shown the stimulatory eﬀect of
IFNγ on the phagocytosis and elimination of C. albicans
by neutrophils and macrophages [39, 40]. In accordance
with these data, we found that C. parapsilosis growth was
reduced following culture in the presence of oral epithelial
cell (Table 2). This situation may mimic the physiologi-
cal and pathological environment in the oral cavity, and
supports previously reported studies related to the growth
inhibition of Candida by epithelial cells [9]. This growth
inhibition may be achieved through the contribution of
antimicrobial peptides. Indeed, our study demonstrates that
following infection with C. parapsilosis, gingival epithelial
cells expressed high levels of HBD-1, HBD-2, and HBD-
3, which conﬁrms the antifungal activity of β-defensins
against C. albicans [41], and suggests the involvement of
these antimicrobial peptides in controlling C. parapsilosis
growth/pathogenesis by epithelial cells.
It is important to note that HBD-4 not only appeared to
be unrequired but even decreased in this antifungal defense,
suggesting the presence of diﬀerent pathways involving12 Mediators of Inﬂammation
HBD-4 separate from the other HBDs. Our results on HBD-
4 conﬁrm those previously reported showing a diﬀerent
eﬀect of HBD-4, depending on the microorganism used
[42]. Indeed, HBD-4 has been shown to display weak
antimicrobial activity against E. coli, S. cerevisiae, S. aureus,
S. pneumoniae,a n dB. cepacea, and strong antimicrobial
activity against S. carnosus and P. aeruginosa [43]. The
eﬀect of HBD-4 remains to be elucidated basically following
infection with Candida.
5. Conclusion
This study demonstrated some key events related to
the interaction between gingival epithelial cell/tissues and
C. parapsilosis. Through this interaction, gingival epithelial
c e l l si n v o l v e dT L R sa n dd i ﬀerent mediators to control C.
parapsilosis pathogenesis. Additional research will neverthe-
less be necessary to fully determine the key events involved
in host/C. parapsilosis interactions and the mechanisms that
prevent C. parapsilosis infection. Epithelial cells could be
instrumental in helping us unravel the opportunistic process
by which C. parapsilosis, found in proximity to humans,
becomes a pathogen.
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